Karo Pharma

Smart choices for everyday healthcare

Karo Pharma
  • About
    • Board of Directors
    • Executive Management
  • Products
  • Karo Everyday
  • Investors
    • The share
    • Financial reports
    • Press releases
    • Calendar
    • Corporate Governance
    • Repurchased shares
    • Public tender offer
  • News & Press
  • English
    • Svenska
    • Dansk
    • Suomi
    • Norsk
    • Deutsch
    • Nederlands

Financial reports

Annual reports

2019, 2018, 2017, 2016, 2015, 2014, 2013

Recent reports

  • Select year
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
18 February, 2021

Year-end report 2020

Q4, October – December Net sales amounted to MSEK 721.2 (649.3). This corresponds to an increase of 11% for the period.The organic growth* during the fourth quarter was +1%. The currency impact in the quarter was -1% while the acquisitions of the product portfolios Proct® from Leo Pharma and Pevaryl® from Johnson & Johnson generated...

  • Products
  • Financial reports
  • Financial Press releases
  • Contact Karo Pharma

Follow us on LinkedIn
Copyright© Karo Pharma AB 2021

Cookies are required for our website to function optimally and to improve the user experience. By browsing further, you accept our use of cookies.» Privacy policy